栄研化学の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/08/10 | 1,442 | 1,446 | 1,425 | 1,446 | -1 | -0.1% | 140,700 |
2023/08/09 | 1,462 | 1,462 | 1,434 | 1,447 | -3 | -0.2% | 124,600 |
2023/08/08 | 1,445 | 1,468 | 1,445 | 1,450 | -5 | -0.3% | 115,200 |
2023/08/07 | 1,440 | 1,460 | 1,431 | 1,455 | +14 | +1% | 75,800 |
2023/08/04 | 1,460 | 1,460 | 1,437 | 1,441 | -25 | -1.7% | 141,800 |
2023/08/03 | 1,493 | 1,493 | 1,466 | 1,466 | -37 | -2.5% | 157,600 |
2023/08/02 | 1,495 | 1,516 | 1,495 | 1,503 | -4 | -0.3% | 114,400 |
2023/08/01 | 1,508 | 1,521 | 1,493 | 1,507 | -2 | -0.1% | 211,600 |
2023/07/31 | 1,551 | 1,566 | 1,500 | 1,509 | -76 | -4.8% | 374,600 |
2023/07/28 | 1,564 | 1,585 | 1,562 | 1,585 | +4 | +0.3% | 123,100 |
2023/07/27 | 1,575 | 1,585 | 1,568 | 1,581 | +6 | +0.4% | 61,900 |
2023/07/26 | 1,585 | 1,585 | 1,567 | 1,575 | -8 | -0.5% | 83,200 |
2023/07/25 | 1,590 | 1,590 | 1,577 | 1,583 | -2 | -0.1% | 61,200 |
2023/07/24 | 1,583 | 1,590 | 1,566 | 1,585 | +16 | +1% | 82,800 |
2023/07/21 | 1,554 | 1,574 | 1,554 | 1,569 | +17 | +1.1% | 93,700 |
2023/07/20 | 1,562 | 1,563 | 1,547 | 1,552 | -15 | -1% | 54,200 |
2023/07/19 | 1,560 | 1,567 | 1,557 | 1,567 | +20 | +1.3% | 72,000 |
2023/07/18 | 1,548 | 1,553 | 1,533 | 1,547 | -5 | -0.3% | 55,100 |
2023/07/14 | 1,563 | 1,565 | 1,547 | 1,552 | +5 | +0.3% | 43,900 |
2023/07/13 | 1,534 | 1,548 | 1,523 | 1,547 | +14 | +0.9% | 82,600 |
2023/07/12 | 1,540 | 1,544 | 1,528 | 1,533 | -15 | -1% | 110,300 |
2023/07/11 | 1,562 | 1,562 | 1,542 | 1,548 | +4 | +0.3% | 85,200 |
2023/07/10 | 1,538 | 1,550 | 1,528 | 1,544 | +6 | +0.4% | 119,800 |
2023/07/07 | 1,536 | 1,548 | 1,527 | 1,538 | +2 | +0.1% | 79,500 |
2023/07/06 | 1,553 | 1,555 | 1,527 | 1,536 | -26 | -1.7% | 131,100 |
2023/07/05 | 1,571 | 1,571 | 1,553 | 1,562 | -10 | -0.6% | 98,300 |
2023/07/04 | 1,563 | 1,579 | 1,558 | 1,572 | +9 | +0.6% | 115,400 |
2023/07/03 | 1,550 | 1,571 | 1,550 | 1,563 | +24 | +1.6% | 129,700 |
2023/06/30 | 1,551 | 1,551 | 1,522 | 1,539 | +2 | +0.1% | 119,600 |
2023/06/29 | 1,519 | 1,537 | 1,518 | 1,537 | +26 | +1.7% | 126,900 |
2023/06/28 | 1,488 | 1,511 | 1,488 | 1,511 | +26 | +1.8% | 108,900 |
2023/06/27 | 1,500 | 1,504 | 1,480 | 1,485 | -25 | -1.7% | 97,300 |
2023/06/26 | 1,525 | 1,525 | 1,503 | 1,510 | -18 | -1.2% | 62,100 |
2023/06/23 | 1,556 | 1,556 | 1,521 | 1,528 | -9 | -0.6% | 100,400 |
2023/06/22 | 1,549 | 1,551 | 1,533 | 1,537 | -12 | -0.8% | 72,600 |
2023/06/21 | 1,558 | 1,566 | 1,546 | 1,549 | -13 | -0.8% | 67,500 |
2023/06/20 | 1,553 | 1,562 | 1,544 | 1,562 | +5 | +0.3% | 78,000 |
2023/06/19 | 1,530 | 1,557 | 1,530 | 1,557 | +27 | +1.8% | 124,300 |
2023/06/16 | 1,515 | 1,530 | 1,513 | 1,530 | +12 | +0.8% | 219,900 |
2023/06/15 | 1,520 | 1,529 | 1,516 | 1,518 | -11 | -0.7% | 93,100 |
2023/06/14 | 1,529 | 1,535 | 1,522 | 1,529 | ±0 | ±0% | 94,300 |
2023/06/13 | 1,543 | 1,546 | 1,529 | 1,529 | -19 | -1.2% | 103,000 |
2023/06/12 | 1,542 | 1,561 | 1,542 | 1,548 | +26 | +1.7% | 181,100 |
2023/06/09 | 1,510 | 1,534 | 1,510 | 1,522 | +3 | +0.2% | 124,600 |
2023/06/08 | 1,523 | 1,523 | 1,506 | 1,519 | +1 | +0.1% | 99,700 |
2023/06/07 | 1,527 | 1,532 | 1,513 | 1,518 | -3 | -0.2% | 81,800 |
2023/06/06 | 1,511 | 1,526 | 1,504 | 1,521 | -4 | -0.3% | 58,200 |
2023/06/05 | 1,528 | 1,537 | 1,522 | 1,525 | +22 | +1.5% | 86,000 |
2023/06/02 | 1,479 | 1,507 | 1,476 | 1,503 | +23 | +1.6% | 81,100 |
2023/06/01 | 1,472 | 1,494 | 1,463 | 1,480 | +5 | +0.3% | 104,800 |
301~
350
件表示中 / 6825件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
栄研化 | 238,100円 | +7.6% | +57.5% | 2.23% | 18.40倍 | 1.81倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 121,200円 | +197.7% | - | 0.00% | 49.53倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 152,000円 | +3.2% | +4.5% | 3.42% | 17.46倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
JCRファーマ | 65,100円 | -3.7% | -36.7% | 3.07% | 22.08倍 | 1.45倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
サンバイオ | 102,000円 | - | - | 0.00% | - | 51.36倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム